导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.32% | 473/1050 |
| 近一周 | -2.36% | 565/1104 |
| 近一月 | -3.61% | 425/1102 |
| 近一季 | -5.81% | 456/1092 |
| 近半年 | -1.08% | 447/1070 |
| 近一年 | 7.29% | 410/1018 |
| 近两年 | 39.89% | 589/926 |
| 近三年 | 29.03% | 404/834 |
| 成立以来 | 29.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.76% 621/1070 |
12.21% 516/1101 |
- - |
- - |
| 2025 | 17.46% 714/1065 |
-1.69% 893/1014 |
2.01% 507/1038 |
13.86% 769/1050 |
2.88% 250/1065 |
| 2024 | 12.94% 218/1011 |
9.65% 31/960 |
-1.35% 396/983 |
10.69% 573/991 |
-5.67% 708/1011 |
| 2023 | -10.45% 345/952 |
-1.80% 700/880 |
2.32% 90/895 |
-6.52% 391/915 |
-4.65% 465/952 |
| 2022 | -29.33% 609/867 |
-17.92% 423/773 |
1.72% 667/806 |
-14.47% 536/845 |
-1.03% 489/867 |
| 2021 | 10.04% 251/740 |
-3.77% 290/580 |
14.43% 248/659 |
0.74% 207/704 |
-0.80% 473/740 |
| 2020 | 55.10% 217/554 |
-6.30% 326/419 |
24.94% 193/466 |
12.82% 183/517 |
17.43% 164/554 |
| 2019 | 29.33% 292/410 |
24.00% 783/1146 |
-3.11% 586/1228 |
1.23% 298/390 |
6.33% 301/410 |
| 2018 | -27.26% 181/349 |
- - |
-11.06% 551/990 |
-4.52% 434/1000 |
-11.18% 413/1080 |
| 2017 | -8.66% 190/285 |
- - |
- - |
- - |
- - |
| 2016 | -3.70% 39/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 大摩量化多策略股票 VS. 东吴新产业精选股票A(580008) |